Insider trade

CFO exercised or converted 12K MRNA derivative securities

Traded Mar 5, 2026 · Filed Mar 6, 2026

ModernaMRNA

12K
Shares

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 5, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 6, 2026

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001682852-26-000049

Filed / recorded

Mar 6, 2026, 9:21 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

Moderna, Inc.

Issuer CIK

1682852

Ticker

MRNA

Reporting person

James M Mock

Relationship

Officer

Officer title

Chief Financial Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Mar 5, 2026

Transaction code

M

Shares / units

11,797

Acquired / disposed

Acquired (A)

Shares owned after

62,702

Ownership form

Direct

Amendment

No

Footnotes from the filing

Restricted stock units convert into common stock on a one-for-one basis.

Around the same time

7mo ago

12KShares

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

7mo ago

5,704Shares · @ $57.80

Routine share withholding; mechanical by default.

Why it stands out Official record

7mo ago

12KDerivative units

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record